However, SPCA2 is over-expressed in the plasma membrane of breast cancer cells, where it directly binds to and activates Orai1, independent of STIM1, and leads to enhanced Ca2+ entry and Ca2+-dependent proliferation [227]. The gene discussed is ATP2C2; the disease is breast carcinoma.